UnknownPHASE2, PHASE3NCT03453632
Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex
Studying Epidermolysis bullosa simplex
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Juliette Mazereeuw-Hautier, MDUniversity Hospital, Toulouse
- Intervention
- Botulinic toxin(drug)
- Enrollment
- 25 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2023
Study locations (4)
- University Hospital Bordeaux, Bordeaux, France
- University Hospital Nice, Nice, France
- Saint-Louis Hospital - APHP, Paris, France
- Hôpital Larrey - CHU Toulouse, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03453632 on ClinicalTrials.govOther trials for Epidermolysis bullosa simplex
Additional recruiting or active studies for the same condition.